Mark S. Black - May 20, 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Director
Signature: /s/ David Patience, attorney-in-fact
Stock symbol: AXDX
Transactions as of: May 20, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/21/2024, 07:04 PM
Previous filing: Jun 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Restricted Stock Units	Award	$0	+66.7K		$0.00	66.7K	May 20, 2024	Common Stock	66.7K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2	On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors.

Content

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.

On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors.